reglab/statecodes huggingface dataset:
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 221.000 - Promoting Awareness Of Meningococcal Disease And Vaccine › Section 221.100 - Purpose

Current through Register 1525, July 5, 2024
The purpose of
				105 CMR 221.000 is to
				implement the provisions of M.G.L. c. 111, § 219.
				105 CMR 221.000 seeks to
				promote awareness of meningococcal disease and vaccine among parents and
				guardians of minor students, and students 18 years of age or older, attending
				certain schools, colleges and universities, and parents and guardians of
				enrollees in certain programs for children.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 221.000 - Promoting Awareness Of Meningococcal Disease And Vaccine › Section 221.200 - Authority

Current through Register 1525, July 5, 2024
105 CMR 221.000 is
				authorized and required by M.G.L. c. 111, § 219.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 221.000 - Promoting Awareness Of Meningococcal Disease And Vaccine › Section 221.200 - Definitions

Current through Register 1525, July 5, 2024
Secondary School
shall mean a school
				or that portion of a school that provides education for students in grades nine
				through 12.
Day Care Center
shall mean any
				facility or program operated on a regular basis, whether known as a day
				nursery, nursery school, kindergarten, child play school, progressive school,
				child development center, pre-school, or entity known under any other name
				which receives children, not of common parentage, under seven years of age, or
				under 16 years of age if the children have special needs for non-residential
				custody and care during part or all of the day separate from their
				parent(s).
Youth Camp
shall mean any day,
				primitive or outpost, residential, sports, travel or trip camp conducted wholly
				or in part for recreation or recreational instruction which:
(a) operates for profit or for philanthropic or charitable
				purposes, whether or not a fee is charged; and
(b) serves five or more children who are not members of the
				family or personal guests of the operator; and
(c) operates for any period of time between June 1 and
				September 30 of any year or not more than 14 consecutive days during any other
				time of the year; or
(d) promotes or advertises itself as a camp. If not promoted or
				advertised as a camp, the following shall not be deemed to be a youth camp:
1. a child care program licensed in accordance with M.G.L. c.
				28A, §10;
2. a single purpose class, workshop, clinic or program
				sponsored by a municipal recreation department, or a neighborhood playground
				activity program;
3. a program operated solely on a drop-in basis;
4. a classroom based instructional program, provided that no
				specialized or high risk activities are conducted as part of the program; and
5. a summer school program accredited by a recognized
				educational accreditation agency.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 221.000 - Promoting Awareness Of Meningococcal Disease And Vaccine › Section 221.300 - Dissemination of Information about Meningococcal Disease and Vaccine

Current through Register 1525, July 5, 2024
In accordance with M.G.L. c. 111, § 219, public and
				private secondary schools, colleges, universities, day care centers, and youth
				camps shall provide to a parent or guardian, or to a student 18 years of age or
				older, with the exception of those students covered by
				105
				CMR 220.700, information approved or provided
				by the Department regarding the risk of meningococcal disease and the
				availability, effectiveness and risks of meningococcal vaccine. Such
				information shall be provided at the time of initial
				enrollment.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.001 - Purpose

Current through Register 1525, July 5, 2024
The purpose of
				105 CMR 222.000 is to
				facilitate and promote the use of the Massachusetts Immunization Information
				System (MIIS) to help improve immunization coverage among all individuals in
				the Commonwealth.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.002 - Scope

Current through Register 1525, July 5, 2024
105 CMR 222.000 applies to
				all health care providers licensed in the Commonwealth who administer
				immunizations in Massachusetts to any person, whether or not that person is a
				resident of the Commonwealth, and any entity that accesses the
				MIIS.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.003 - Definitions

Current through Register 1525, July 5, 2024
Department
means the Massachusetts
				Department of Public Health.
EHR
means an electronic health
				record.
Electronic Data Exchange
means the
				electronic interchange of information or data using a standardized format that
				allows one entity to send information to another electronically rather than
				with paper.
GUI
means a web-based graphical user
				interface.
Health Care Provider
means a health
				care professional who administers immunizations and is licensed under M.G.L. c.
				112 and pharmacists authorized by
				105 CMR 700.004(B)(6)
				 to dispense vaccine by
				administration.
Immunization
means a vaccine or
				immunoglobulin, identified on a list maintained by the Department that
				introduces active or passive immunity to a specific disease or group of
				diseases.
MIIS
means the Massachusetts
				Immunization Information System.
MIIS Fact Sheet
means the MIIS Fact
				Sheet for Parents and Parents
MRVRS
means the Massachusetts Registry
				of Vital Records and Statistics.
Objection to Data Sharing
means an
				individual's immunization information will be accessible only to Department
				staff and the provider that entered the immunization information.
Objection Form
means a mechanism as
				determined by the Department by which an individual may indicate an objection
				to sharing immunization information across providers that access the
				MIIS.
VIS
means Vaccine Information
				Statements, which are information sheets produced by the Centers for Disease
				Control and Prevention (CDC) that explain to vaccine recipients, their parents,
				or their legal representatives the risks and benefits of a vaccine.
VFC
means the federal Vaccines For
				Children Program.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.100 - Health Care Provider Immunization Information Reporting

Current through Register 1525, July 5, 2024
(A) Health care providers shall report all
			 new immunizations either through the GUI or by data exchange within seven days
			 of immunization administration.
(B)
			 Health care provider sites that perform data exchange shall comply with all
			 electronic data exchange specifications required by the Department.
(C) Health care provider sites performing
			 electronic data exchange shall send complete immunization records with all new
			 immunizations being reported to the system. If sites are unable to send
			 complete records, they may perform a one-time historical upload of records into
			 the MIIS in a form and manner determined by the Department.
(D) Data for each individual reported through
			 the GUI shall include at a minimum:
(1) For
			 both current and historical immunizations, the full first and last name and
			 date of birth of the individual, immunization type, and date of immunization
			 administration;
(2) For current
			 immunizations, VFC status, individual's current home address, immunization
			 manufacturer and lot number, name, address, and title of the person
			 administering the immunization, edition date printed on the appropriate VIS,
			 and date the VIS was given to the individual or the individual's parents/legal
			 representative (if younger than 18 years old); and
(3) Any other information as determined by
			 the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.105 - Duty to Inform

Current through Register 1525, July 5, 2024
(A) Providers shall
			 explain to individuals, or the parent or legal guardian of an individual under
			 18 years of age, the MIIS reporting procedures and requirements for
			 immunization information for all individuals to the MIIS, including the right
			 to object to data sharing, as described in 105 CMR 222.105(C).
(B) Written materials developed by the
			 Department for this purpose may include: MIIS Fact Sheet, posters, sample
			 language for individual registration forms, sample provider email or template
			 letters for informing individuals, MIIS Objection (or Withdrawal of Objection)
			 Form. These materials will be maintained and updated by the
			 Department.
(C)
Objection/Withdrawal of Objection Procedures
.
(1) If an individual, or the parent or
			 guardian of an individual younger than 18 years old, chooses to object to data
			 sharing (or withdraw objection to data sharing) in the MIIS, the individual
			 must complete the Objection Form and submit it either to his or her health care
			 provider or directly to the Department.
(2) If an Objection Form is received directly
			 by a provider, the provider must fax the form to the Department within 24 hours
			 of receipt. Providers must also change the data sharing status of the
			 individual in the GUI in order to ensure the Objection or Withdrawal of
			 Objection is implemented within the system immediately, as practical.
(3) The records of an individual whose data
			 sharing is changed from "Yes" or "Unknown" to "No" will be accessible only by
			 the provider site that entered the immunization information.
(4) An individual who has objected to data
			 sharing, but whose name is not yet in the MIIS, will be added to the system and
			 will have data sharing status set to "No" by the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.200 - Provider Enrollment

Current through Register 1525, July 5, 2024
(A) Health care
			 provider sites shall review and complete the Provider Site Enrollment Agreement
			 prior to enrolling individual users at their site in the MIIS.
(B) Health care providers shall enroll and
			 agree to comply with all terms and conditions set forth in the MIIS Individual
			 User Agreement and Confidentiality Statement prior to receiving access to the
			 MIIS either through the GUI or electronic data exchange. Signed individual user
			 agreements shall be sent to Department and copies maintained at the provider
			 site.
(C) Department may at any
			 time revoke access to the MIIS from any user who fails to comply with the MIIS
			 Individual User Agreement and Confidentiality Statement.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.205 - System Access and Confidentiality

Current through Register 1525, July 5, 2024
(A)
			 Immunization information shall be released from the MIIS only to the following
			 individuals and agencies without further expressed consent of the individual or
			 the individual's parent or guardian unless the individual or the individual's
			 parent or guardian has objected to data sharing:
(1) Licensed health care providers and their
			 staff providing direct care to the individual patient;
(2) Elementary and secondary school nurses
			 and registration officials who require proof of immunization for school
			 enrollment and disease control;
(3)
			 Local boards of health for disease prevention and control;
(4) Women Infants and Children (WIC)
			 nutrition program staff who administer WIC benefits to eligible infants and
			 children; and
(5) Staff of state
			 agencies or state programs whose duties include education and outreach related
			 to the improvement of immunization coverage rates among their
			 clients.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.300 - Requests to Amend Records and Access Records by Individuals

Current through Register 1525, July 5, 2024
(A) Incorrect information may be amended by
			 an individual's health care provider or by any health care provider if the
			 individual has not objected to data sharing in the MIIS.
(B) Requests for record amendments may also
			 be made directly to the Department in writing in a form and manner determined
			 by the Department.
(C) Requests for
			 copies of records by individuals should be made to their health care provider.
			 Such requests may be made in person and the health care provider filling the
			 request shall validate the individual's identity, and in the case of a minor's
			 record, validate that the individual is the legal guardian or parent of the
			 minor. Requests may also be made directly to the Department in writing in a
			 form and manner determined by the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.305 - Requests for List of Those Who Have Accessed Records

Current through Register 1525, July 5, 2024
Requests for a record of all MIIS users that have accessed an
				individual's immunization information shall be made in writing in a form and
				manner determined by the Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 222.000 - Massachusetts Immunization Information System › Section 222.400 - Compliance Schedule

Current through Register 1525, July 5, 2024
All health care providers licensed in the Commonwealth who
				administer immunizations in Massachusetts to any person, whether or not that
				person is a resident of the Commonwealth, shall be in compliance with
				105 CMR 222.000 according
				to a schedule to be determined and distributed by the
				Department.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.001 - Scope and Purpose

Current through Register 1525, July 5, 2024
105 CMR 223.000 governs the
				procedures for collecting an assessment to fund the Pediatric Immunization
				Program. The assessment is a surcharge on certain payments made to
				Massachusetts acute hospitals and ambulatory surgical
				centers.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.002 - Authority

Current through Register 1525, July 5, 2024
105 CMR 223.000 is adopted
				pursuant to St. 2013, c. 38, Line Item 4580-1000 and M.G.L. c. 111, §
				3.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.100 - Determination of Assessment Liability and Payment

Current through Register 1525, July 5, 2024
(A) The Department shall collect an
			 assessment on certain payments to hospitals and ambulatory surgical centers.
			 The assessment amount equals the product of
(1) payments subject to the assessment as
			 defined in 105 CMR 223.100(C); and
(2) the assessment percentage as defined in
			 105 CMR 223.100(D).
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.200 - Administrative Review

Current through Register 1525, July 5, 2024
(A) The Department
			 may conduct an administrative review of assessment liability payments at any
			 time.
(B) The Department will
			 review data submitted by hospitals, ambulatory surgical centers, and any other
			 relevant data, including surcharge data. All information provided by, or
			 required from, any payer, pursuant to
			 105 CMR 223.000 shall be
			 subject to audit by the Department. For assessment liability payments based
			 upon a global fee or capitation payment allocated according to an allocation
			 method accepted by the Department pursuant to
			 105 CMR
			 223.100(F), the Department's
			 review will be limited to determining whether this method was followed
			 accurately and whether the amounts reported were accurate.
(C) The Department may require the payer to
			 submit additional documentation reconciling the data it submitted with data
			 received from hospitals and ambulatory surgical centers.
(D) If the Department determines through its
			 review that a payer's assessment liability payment was materially incorrect,
			 the Department will require a payment adjustment.
(1)
Notification
.
			 The Department shall notify the payer in writing if it determines there should
			 be a payment adjustment. The notification will include a detailed explanation
			 of the proposed adjustment.
(2)
Objection Process
. A payer may object to proposed
			 adjustment in writing, within 15 business days of the mailing of the
			 notification letter. The payer may request an extension of this period for
			 cause. The written objection must, at a minimum, contain:
(a) the specific reason(s) for each of the
			 payer's objections; and
(b) all
			 documentation that supports the payer's position.
(3)
Written
			 Determination
. Following review of the payer's objection, the
			 Department will notify the payer of its determination in writing, with an
			 explanation of its reasoning.
(4)
Payment of Adjustment Amounts
. Payment of adjustment
			 amounts are due within 30 days following the mailing of the determination
			 letter.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.300 - Other Provisions

Current through Register 1525, July 5, 2024
(1)
Reporting Requirements
. Each payer shall file or make
			 available information that is required or that the Department deems reasonably
			 necessary for calculating and collecting the assessment.
(2)
Administrative
			 Bulletins
. The Department may issue administrative bulletins to
			 clarify policies, update administrative requirements, and specify information
			 and documentation necessary to implement
			 105 CMR 223.000.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 223.000 - Pediatric Immunization Program Assessment › Section 223.400 - Severability

Current through Register 1525, July 5, 2024
The provisions of
				105 CMR 223.000 are
				severable. If any provision or the application of any provision is held to be
				invalid or unconstitutional, such invalidity shall not be construed to affect
				the validity or constitutionality of any remaining provisions of
				105 CMR 223.000 or the
				application of such provisions.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 225.000 - Nutrition Standards For Competitive Foods And Beverages In Public Schools › Section 225.001 - Purpose

Current through Register 1525, July 5, 2024
The purpose of
				105 CMR 225.000 is to
				establish nutrition standards for competitive foods and beverages sold or
				provided in public schools. The goal of
				105 CMR 225.000 is to
				ensure that students are offered nutritious food and beverage choices that will
				enhance learning, contribute to healthy growth and development, and cultivate
				lifelong healthy eating behaviors.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 225.000 - Nutrition Standards For Competitive Foods And Beverages In Public Schools › Section 225.002 - Scope and Application

Current through Register 1525, July 5, 2024
In accordance with M.G.L. c. 111, § 223,
				105 CMR 225.000 establishes
				nutrition standards for competitive foods and beverages sold or provided in
				public schools. Public schools must implement the requirements of
				105 CMR 225.000 by August
				1, 2012.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 225.000 - Nutrition Standards For Competitive Foods And Beverages In Public Schools › Section 225.100 - General Nutrition Standards for Public Schools

Current through Register 1525, July 5, 2024
(A) All competitive foods and beverages sold
			 or provided in public schools shall comply with the nutrition standards of
			 105 CMR 225.000; provided,
			 however, that:
(1) unless otherwise
			 determined by the public school district or board of trustees,
			 105 CMR 225.000 shall not
			 apply to competitive foods and beverages sold on school grounds beyond 30
			 minutes after the end of the school day;
(2)
									105 CMR 225.000 shall apply
			 at all times to competitive foods sold through vending machines;
(3)
									105 CMR 225.000 shall not
			 apply at any time to competitive foods or beverages sold or provided at booster
			 sales, concession stands and other school-sponsored or school-related
			 fundraisers and events; and
(4)
									105 CMR 225.000 shall not
			 apply at any time to fresh, frozen, and canned fruits and vegetables with no
			 added ingredients except water, or 100% juice in the case of canned and frozen
			 fruits.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 225.000 - Nutrition Standards For Competitive Foods And Beverages In Public Schools › Section 225.200 - Specific Nutrition Standards for Competitive Foods in Public Schools

Current through Register 1525, July 5, 2024
(A)
Beverages
.
(1)
Juice
.
(a) All juice shall be made of 100% fruit or
			 vegetable juice, with no added sugar, and may or may not be diluted with water
			 or carbonated water.
(b) Servings
			 of juice shall be no more than eight ounces.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.001 - Purpose

Current through Register 1525, July 5, 2024
105 CMR 240.000 establishes
				criteria for determining whether certain health care providers and insurers
				will be required under St. 1993, c. 458 to provide coverage for bone marrow
				transplants for breast cancer patients. Nothing in
				105 CMR 240.000 shall be
				interpreted as preventing a healthcare provider or insurer covered by
				105 CMR 240.000 from
				providing additional coverage for bone marrow transplants for breast cancer
				patients where appropriate under eligibility criteria established by the health
				care provider or insurer.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.002 - Authority

Current through Register 1525, July 5, 2024
105 CMR 240.000 is
				promulgated pursuant to St. 1993, c. 458 and M.G.L. c. 111, §
				5.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.003 - Scope

Current through Register 1525, July 5, 2024
105 CMR 240.000 applies to
				breast cancer patients with insurance coverage provided under one of the
				following:
(A) an individual policy of
			 accident and sickness insurance issued pursuant to M.G.L. c. 175, §
			 108;
(B) a group blanket policy of
			 accident and sickness insurance issued pursuant to M.G.L. c. 175, §
			 110;
(C) a contract between a
			 subscriber and corporation under an individual or group hospital service plan
			 delivered, issued or renewed pursuant to M.G.L. c. 176A, for all individual
			 subscribers or members within the Commonwealth and all group members having a
			 principal place of employment within the Commonwealth;
(D) a subscription certificate under an
			 individual or group medical service contract delivered, issued or renewed
			 pursuant to M.GL. c. 176B, for all individual subscribers or members within the
			 Commonwealth and all group members having a principal place of employment
			 within the Commonwealth;
(E) a
			 group health maintenance contract under M.G.L. c. 176G;
(F) a plan for any active or retired employee
			 of the Commonwealth offered by the Group Insurance Commission pursuant to
			 M.G.L.c.32A.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.004 - Definitions

Current through Register 1525, July 5, 2024
Metastatic disease
, for purposes of
				105 CMR 240.000, shall mean
				Stage III and Stage IV breast cancer, as well as Stage II breast cancer which
				has spread to tenor more lymph nodes, as defined by the American College of
				Surgeons.
Bone Marrow Transplant
, for purposes
				of
				105 CMR 240.000, shall mean
				use of high dose chemotherapy and radiation in conjunction with transplantation
				of autologous bone marrow or perhipheral blood stem cells which originate in
				the bone marrow.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.005 - Insurance Coverage for Eligible Patients

Current through Register 1525, July 5, 2024
(A) Health care providers, benefits managers
			 and insurers shall work cooperatively with patients with metastatic breast
			 cancer to identify appropriate clinical trials involving the use of bone marrow
			 transplants and provide coverage for bone marrow transplantation, in accordance
			 with the eligibility criteria specified in
			 105 CMR 240.000. Health
			 care providers or insurers specified in
			 105 CMR 240.003 who make
			 treatment available through a network of participating providers may use the
			 network to provide bone marrow transplants, in accordance with the requirements
			 of
			 105 CMR 240.000. If bone
			 marrow transplantation is not available through the network, the health care
			 provider or insurer may arrange and shall provide coverage for a bone marrow
			 transplant meeting the requirements of
			 105 CMR 240.000.
(B) With respect to patients who have been
			 diagnosed with breast cancer that has progressed to metastatic disease, the
			 health care providers and insurers specified in
			 105 CMR 240.003 shall:
(1) permit referral to and participation in
			 clinical trials when an oncologist recommends participation on the grounds that
			 the proposed procedure shows promise as a useful treatment for that patient, a
			 nd the proposed procedure is likely to be at least as effective as conventional
			 treatment for that patient; and
(2)
			 provide coverage for a bone marrow transplant, in accordance with 105 CMR
			 240.005(A), if the patient meets the eligibility criteria for enrollment into a
			 clinical trial meeting the requirements of
			 105 CMR
			 240.006, even if the patient is not formally
			 enrolled in that clinical trial;
(3) provide coverage for a bone marrow
			 transplant to the extent that benefits generally are provided for other medical
			 procedures.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.006 - Suitable Clinical Trials

Current through Register 1525, July 5, 2024
The health care providers and insurers specified in
				105 CMR 240.003 shall
				provide coverage for bone marrow transplantation, in accordance with
				105 CMR 240.000, where the
				patient has been found to meet the eligibility criteria for a clinical trial
				satisfying the requirements of 105 CMR 240.006. The clinical trial shall be
				conducted in accordance with a protocol approved by an institutional review
				board meeting the requirements for the protection of human subjects specified
				in 45 CFR Part 46. In addition, the clinical trial shall be conducted:
(A) at a licensed health facility which is
			 located at the principal site of an academic medical center which participates
			 in NCI sponsored or approved research in any cancer specialty area;
			 or
(B) at a licensed health
			 facility which has a formal affiliation agreement with an academic medical
			 center to provide bone marrow transplantation as part of an NCI sponsored or
			 approved research protocol.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.007 - Appeal

Current through Register 1525, July 5, 2024
Where a breast cancer patient is denied coverage by a health
				care or insurance provider specified in
				105 CMR 240.003, and claims
				to be eligible for bone marrow transplantation under
				105 CMR 240.000, an
				independent and impartial appeal process shall be made available to the
				patient.
(A) The patient may be
			 required by the health care or insurance provider to exhaust available internal
			 appeals procedures; provided, however, that if the matter is not resolved
			 internally to the patient's satisfaction within 30 days of initiating the
			 appeal, the health care provider or insurer shall refer the matter for final
			 resolution to an impartial and independent review board meeting the
			 requirements of 105 CMR 240.007.
(B) The Department shall establish a list of
			 review boards to which the health provider or insurer may refer an appeal
			 required under 105 CMR 240.007. Review boards may be included in the list if
			 the Department has reason to believe that they will conduct an impartial,
			 independent, fair and timely review of appeals.
(C) If the health provider or insurer
			 utilizes a review board from the Department's list for its own internal appeals
			 process, such review shall satisfy the requirement for an impartial and
			 independent appeal under 105 CMR 240.007.
(D) In the event that the Department is not
			 satisfied with the impartiality, independence, timeliness or fairness of
			 appeals boards seeking to be or already listed, the Department may establish
			 its own appeals board, to be comprised of members of the medical, insurance,
			 and consumer communities.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.008 - Patient Information and Education

Current through Register 1525, July 5, 2024
The Department of Public Health shall make available to
				physicians and patients information about options for participation in clinical
				trials involving bone marrow transplants.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients › Section 240.009 - Advisory Board

Current through Register 1525, July 5, 2024
The Department shall establish an advisory board, comprised of
				representatives of the medical, insurance, and consumer communities, to advise
				the Department on matters pertaining to bone marrow transplants for breast
				cancer patients. Such advisory board shall meet as of tenas necessary, but no
				less than three times a year, in accordance with procedures established by the
				Department. The advisory board shall advise the Department as to the
				following:
(A) the desirability, based
			 upon current research and medical data, of amending the eligibility criteria
			 for bone marrow transplants for breast cancer patients established in
			 105 CMR 240.000. In
			 particular, the advisory board shall advise the Department as to whether there
			 is evidence that bone marrow transplants for a particular stage of cancer not
			 covered by
			 105 CMR 240.000 shows
			 promise of being a useful treatment for that stage and is likely to be at least
			 as effective as conventional treatment;
(B) the desirability of amending the list
			 developed by the Department of impartial and independent review
			 boards;
(C) the appropriateness of
			 amending the criteria for suitable sites for bone marrow transplantation
			 established in
			 105 CMR
			 240.006; and
(D) any matter affecting the implementation
			 of St. 1993, c. 458 or
			 105 CMR 240.000.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 260.000 - Prohibition Against Certain Fishing In New Bedford Harbor › Section 260.001 - Findings and Purpose

Current through Register 1525, July 5, 2024
The chemical substances known as polychlorinated biphenyls
				(PCBs) have been discharged into the Acushnet River and are present in that
				river and in the New Bedford Harbor. Laboratory analyses of lobster and
				bottom-feeding fishcaught in this area have revealed that PCBs are present in
				these food sources in levels that exceed the current maximum allowable levels
				(or "temporary tolerance") established by the Federal Food and Drug
				Administration under the Food and Drug Cosmetic Act,
				21
				U.S.C. 301, § 346. Consumption of PCBs
				causes diseases deemed dangerous to the public health, namely PCB intoxication
				and carcinogenesis.
				105 CMR 260.000 are
				promulgated to prevent and control the incidence of such diseases among members
				of the general public, and to prevent the sale of adulterated food to the
				public.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 260.000 - Prohibition Against Certain Fishing In New Bedford Harbor › Section 260.002 - Emergency Promulgation

Current through Register 1525, July 5, 2024
PCBs settle to the floor of the body of water into which they
				are discharged; they may remain there for decades. Because lobsters and certain
				fish are bottom-feeders, they take in PCBs which remain in their bodies in
				unacceptably high concentrations. These food sources are currently being taken
				from contaminated areas (as described in
				105 CMR
				260.005 ) for primarily recreational and
				other noncommercial purposes and are being consumed by the public. Consumption
				of these food sources by humans poses an immediate and lasting threat to
				health. Further public consumption of these overly-contaminated food sources
				must be avoided by immediately preventing the taking, sale, and thereby the
				eating of such food sources caught in the contaminated area. Immediate adoption
				of
				105 CMR 260.000 is
				necessary for the preservation of the public health; observance of the
				requirements of notice and public hearing, generally required under the first
				paragraph of M.G.L. c. 30A, § 2 prior to the promulgation of regulations,
				would be, in this situation, contrary to the public interest.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 260.000 - Prohibition Against Certain Fishing In New Bedford Harbor › Section 260.003 - Authority

Current through Register 1525, July 5, 2024
105 CMR 260.000 is
				promulgated under authority of M.G.L. c. 111, § 5 and 6, M.G.L. c. 94,
				§ 186 and 192, M.G.L. c. 30A, § 2.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 260.000 - Prohibition Against Certain Fishing In New Bedford Harbor › Section 260.004 - Adulterated Fish

Current through Register 1525, July 5, 2024
Fish, containing levels of PCBs exceeding the maximum allowable
				level (or "temporary tolerance") of PCBs established by the Federal Food and
				Drug Administration for the edible portion of such food sources are adultered
				within the meaning of M.G.L. c. 94, § 186, first paragraph under food.
				Such food sources caught in the contaminated area are presumed to be
				contaminated.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 260.000 - Prohibition Against Certain Fishing In New Bedford Harbor › Section 260.005 - Taking and/or Sale of Lobsters and Certain Fish Prohibited

Current through Register 1525, July 5, 2024
(1) No person shall take and/or sell any fish
			 (except bait fish), lobster or shellfish from the area of New Bedford Harbor
			 (Area I) described below:
The waters north of the Hurricane Dyke in New Bedford
				Harbor.
(2) No person shall
			 take and/or sell any lobster or bottom feeding fish (including eels, scup,
			 flounder and tautog) from the area of New Bedford Harbor (Area II) described in
			 105 CMR 260.005(4):
The waters generally south of area I and north of a line
				extending from Ricketson's Point in South Dartmouth westerly to Wilbur Point on
				Sconticut Neck.
(3) No
			 person shall take and/or sell lobsters from the area of New Bedford Harbor
			 (Area III) described in 105 CMR 260.005(4):
The waters generally south of area II and north of a line
				extending from Mishaum Point on Smith Neck in the town of Dartmouth north and
				west to Gong "3" on Hursett Rock off New Bedford Harbor and continuous north
				and westto Rocky Point on West Island in the town of Fair haven.
(4)
Map of New Bedford
			 Harbor Outlining Areas I, II and III
Click to
				view image
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.001 - Purpose

Current through Register 1525, July 5, 2024
The purposes of
				105 CMR 270.000 are
				to:
(A) list those diseases and
			 disorders with treatments that are known to be more effective if the condition
			 is identified in the newborn/infant period and for which there is a reliable
			 and effective blood screening test and diagnostic protocol; and
(B) ensure that every newborn is screened for
			 markers of these diseases and disorders; and
(C) make available Optional Newborn Blood
			 Screening for another set of diseases and disorders with treatments that are
			 thought to be effective if the condition is identified in the newborn/infant
			 period and for which testing shall be offered under an optional protocol to
			 collect critical population-based data on prevalence of these diseases and
			 disorders in the Massachusetts population, their natural history, and the
			 efficacy of screening, diagnostic, and treatment protocols.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.005 - Newborn Blood Screening Advisory Committee

Current through Register 1525, July 5, 2024
(A)
			 The Commissioner shall establish a permanent advisory committee to advise the
			 Department on matters pertaining to the Newborn Blood Screening Program
			 including, but not limited to:
(1) the
			 listing of treatable diseases and disorders for which newborn blood screening
			 should be mandated or offered as optional newborn blood screening;
(2) how to best provide newborn screening
			 services for the residents of the Commonwealth;
(3) quality assurance and control measures
			 utilized for the operation of the Newborn Blood Screening Program;
			 and
(4) new and emerging research
			 in newborn screening.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.006 - Diseases and Disorders Included in Newborn Blood Screening

Current through Register 1525, July 5, 2024
(A)
Mandated Newborn Blood
			 Screening
. The following diseases and disorders shall be included
			 in mandated newborn screening:
(1)
Inborn Errors of Metabolism
.
(a)
Amino Acid
			 Disorders
:
1. Maple Syrup Urine
			 Disease (MSUD);
2. Homocystinuria
			 (HCY);
3. Phenylketonuria
			 (PKU);
4. Tyrosinemia, Type I (TYR
			 I).
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.007 - Collection and Submission of Newborn Blood Specimens

Current through Register 1525, July 5, 2024
(A) Except as provided in 105 CMR 270.007(C),
			 the health care provider attending a newborn shall ensure that a blood specimen
			 is collected from the newborn between 24 and 48 hours after the birth. If a
			 newborn child is discharged within the first 24 hours after the birth, the
			 health care provider attending a newborn shall ensure that a blood specimen is
			 collected prior to discharge and shall instruct the parents/guardians of the
			 newborn to have a second specimen collected from the newborn within 48 hours of
			 birth. The health care provider of a child after discharge from the birth
			 hospital shall ensure that any repeat specimens requested by the Newborn Blood
			 Screening Program are collected.
(B) The health care provider attending a
			 newborn shall ensure that the blood specimen is collected from the newborn
			 using the filter paper blood collection device provided by the Newborn Blood
			 Screening Program and shall ensure that the specimen is submitted within 24
			 hours of collection or at next available specimen shipment for delivery to the
			 Newborn Blood Screening Program in accordance with directions provided on the
			 device and other supplemental information that may be provided by the Newborn
			 Blood Screening Program. All information requested must be provided on the form
			 associated with the device.
(C) If
			 any parent or guardian objects to mandated newborn blood screening, the health
			 care provider attending a newborn shall provide information about the benefits
			 of mandated newborn screening and about the risks of refusing mandated newborn
			 screening. A translator should be provided if necessary. If all of the infant's
			 parents or guardians with legal custody refuse mandated newborn blood screening
			 based on a conflict with their religious tenets and practices after being
			 provided this information, the health care provider attending a newborn shall
			 not conduct the newborn blood screening required by 105 CMR 270.007(A) and
			 shall document the refusal on a form provided by the Newborn Blood Screening
			 Program. The completed and signed form shall be sent to the Newborn Blood
			 Screening Program and to the infant's health care provider of record.
(D) The health care provider attending a
			 newborn shall ensure that a copy of the Newborn Screening Program brochure is
			 provided to parents or guardians to inform them about the mandated screening
			 tests and the availability of optional screening for pilot studies as specified
			 in
			 105 CMR
			 270.006(B).
(E) The health care provider attending a
			 newborn shall ensure that the consent and documentation procedures, as
			 specified by the Newborn Blood Screening Program, are followed.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.008 - Newborn Blood Screening Fees

Current through Register 1525, July 5, 2024
The Newborn Blood Screening Program shall bill the hospital of
				birth, or the parents for out-of-hospital births, a reasonable charge for the
				testing of newborns for those diseases or disorders screened for pursuant to
				105 CMR
				270.006 and for notification and follow-up to
				ensure treatment of affected newborns.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.009 - Notification of Newborn Blood Screening Test Results

Current through Register 1525, July 5, 2024
The Newborn Blood Screening Program shall notify the hospital
				of birth and the health care provider listed by the hospital on the newborn
				screening collection device or the health care provider determined to be the
				infant's health care provider of the results of the newborn blood screening
				tests as soon as feasible. The infant's health care provider shall notify the
				parent or guardian of the newborn of the newborn's screening test
				results.
The Newborn Blood Screening Program shall provide to the health
				care provider, upon request, the results of all or specified newborn blood
				screening tests for his or her patient.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.010 - Follow-up of Newborn Blood Screening

Current through Register 1525, July 5, 2024
For the purposes of quality assurance, quality improvement and
				ongoing evaluation of the effectiveness of the Newborn Blood Screening Program,
				including the determination of those disorders and diseases that should be
				included in the Department's Newborn Blood Screening Program, the health care
				provider shall report to the Newborn Blood Screening Program, upon request, the
				following information within 30 days of the request:
(A) Diagnostic and long term outcomes for all
			 newborns whose newborn screening results warranted diagnostic evaluation for a
			 newborn screening disorder or disease; and
(B) Any additional, relevant information
			 regarding these diagnostic and long term outcomes as specified by the Newborn
			 Blood Screening Program.
Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders › Section 270.011 - Confidentiality of Newborn Screening Test Results and Information

Current through Register 1525, July 5, 2024
(A) The Newborn Blood Screening Program shall
			 maintain the confidentiality of testing results generated by the Program and
			 information submitted to the Program for purposes of newborn screening and
			 follow-up of newborn testing.
(B)
			 Other than as required for routine notification of newborn blood testing as
			 described in
			 105 CMR
			 270.009, the Newborn Blood Screening Program
			 shall not disclose newborn screening results or any information or patient
			 identifiers which because of name, identifying number, mark or description can
			 be readily associated with a particular individual or the individual's
			 parents/guardians, or any newborn screening information that could be used in
			 combination with other information to identify an individual, except to:
(1) that individual;
(2) the individual's parents or guardians if
			 a minor;
(3) the executor or
			 administrator of the individual's estate;
(4) anyone authorized in writing by that
			 individual or the individual's legal representative;
(5) authorized Department and New England
			 Newborn Screening Program personnel;
(6) authorized staff at other state newborn
			 screening programs responsible for the follow up of the particular
			 newborn;
(7) anyone authorized to
			 receive such information pursuant to a court order; or
(8) any researcher approved by the Department
			 to conduct a specific study pursuant to M.G.L. c. 111, § 24A, and when
			 approved by the Department's or the University of Massachusetts Medical
			 School's Institutional Review Board. Except as provided in 105 CMR 270.011(C),
			 newborn screening information or data that could be used to identify an
			 individual shall not be disclosed to a researcher without the written consent
			 of a parent or guardian.